These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3222139)

  • 1. [Radiosensitizing effect of the nitroimidazole derivatives RK28 and DNIE on murine tumors].
    Tanaka M; Fukuda H; Nakajima T; Sugimoto K; Onoyama Y; Hori H; Inayama S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct; 48(10):1249-60. PubMed ID: 3222139
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of the hypoxic cell radiosensitizer,a dinitroimidazole derivative, on murine tumors].
    Tanaka M; Nakajima T; Fukuda H; Kida A; Tsumura M; Sakashita M; Onoyama Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1986 Dec; 46(12):1442-3. PubMed ID: 3822789
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
    Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
    Ohizumi Y; Murayama C; Maezawa H; Mori T
    Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing of new hypoxic cell sensitizers in vivo.
    Stone HB; Sinesi MS
    Radiat Res; 1982 Jul; 91(1):186-98. PubMed ID: 6212963
    [No Abstract]   [Full Text] [Related]  

  • 6. [Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors].
    Tada T; Nakajima T; Onoyama Y; Nagasawa H; Hori H; Inayama S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):688-90. PubMed ID: 1508643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies in radiosensitizing effects of misonidazole and SR-2508 on experimental animal tumors].
    Ono K; Takahashi M; Hamanaka D; Hiraoka M; Nishidai T; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Feb; 43(2):370-6. PubMed ID: 6223274
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiosensitizing effect of combined radiotherapy, hyperthermia and misonidazole on C3H mouse FM3A tumor.
    Yamashita M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Sep; 44(9):1181-8. PubMed ID: 6522270
    [No Abstract]   [Full Text] [Related]  

  • 9. [Radiosensitization of C3H/He mammary carcinoma by administration of hyperthermia and/or of misonidazole (author's transl)].
    Suyama S; Yabumoto E; Furunishi H; Kawanishi K; Yamazaki T; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981; 41(10):998-1003. PubMed ID: 7335473
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor.
    Lehman CM; Stewart JR
    Radiat Res; 1983 Dec; 96(3):628-34. PubMed ID: 6657927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative efficacy of high-pressure oxygen and misonidazole to reduce TCD50 of a mouse mammary carcinoma.
    Suit HD; Brown JM
    Br J Radiol; 1979 Feb; 52(614):159-60. PubMed ID: 427373
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of local tumour control by misonidazole and hyperthermia.
    Stone HB
    Br J Cancer Suppl; 1978 Jun; 3():178-83. PubMed ID: 277222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumour cells in vivo and in vitro.
    Rockwell S
    Br J Cancer Suppl; 1978 Jun; 3():212-5. PubMed ID: 277230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual function nitroimidazoles less toxic than RSU 1069: selection of candidate drugs for clinical trial (RB 6145 and/or PD 130908.
    Cole S; Stratford IJ; Fielden EM; Adams GE; Leopold W; Elliott W; Suto M; Sebolt-Leopold J
    Int J Radiat Oncol Biol Phys; 1992; 22(3):545-8. PubMed ID: 1735694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of hyperbaric oxygen and misonidazole in fractionated irradiation of murine tumors.
    Suit HD; Maimonis P; Michaels HB; Sedlacek R
    Radiat Res; 1981 Aug; 87(2):360-7. PubMed ID: 7268001
    [No Abstract]   [Full Text] [Related]  

  • 16. Combinations of radiation and misonidazole in a murine lung tumor model.
    Siemann DW; Kochanski K
    Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
    McNally NJ; Denekamp J; Sheldon P; Flockhart IR; Stewart FA
    Radiat Res; 1978 Mar; 73(3):568-80. PubMed ID: 273269
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of artificial lung metastases by misonidazole.
    Rockwell S; Nierenburg M; Irvin CG
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1395-8. PubMed ID: 6469763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
    Overgaard J; Overgaard M; Nielsen OS; Pedersen AK; Timothy AR
    Br J Cancer; 1982 Dec; 46(6):904-11. PubMed ID: 7150484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma.
    Denekamp J; Harris SR
    Radiat Res; 1975 Feb; 61(2):191-203. PubMed ID: 1110975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.